Viewing Study NCT02394093


Ignite Creation Date: 2025-12-25 @ 1:22 AM
Ignite Modification Date: 2026-03-03 @ 4:17 AM
Study NCT ID: NCT02394093
Status: COMPLETED
Last Update Posted: 2016-09-19
First Post: 2015-03-14
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: To Evaluate the Bioavailability of a Single Oral Dose of the Acetylsalicylic Acid Containing Dry Powder 500 mg in Comparison to the Bioavailability of a Single Oral Dose of Aspirin Tablets and Aspirin Effervescent Tablets in Healthy Adults.
Sponsor: Bayer
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module